Clover Health Investments, Corp.

CLOV Nasdaq SEC CIK 1801170
Follow Clover Health Investments, Corp. Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $759.3M +52.9% vs same quarter last year
Net income $6.4M +126.4% vs same quarter last year
EPS, diluted $0.01 +120% vs same quarter last year
Operating cash flow $70.4M +481.5% vs same quarter last year
Revenue by quarter
$337M
$462.3M
$477.6M
$496.7M
$487.7M
$749.2M
$743.2M
$759.3M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income8 fiscal years
  • Revenue
  • Net income
−$1B$0$1B$2BFY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$1.9B−$85.5M
FY24$1.4B−$43M
FY23$1.3B−$213.4M
FY22$1.1B−$338.8M
FY21$1.5B−$587.8M
FY20$672.9M−$136.4M
FY19$462.3M−$363.7M
FY18--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−100%−75%−50%−25%0%25%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY25-−4.4%−4.4%
FY24-−3.3%−3.1%
FY2320.4%−16.3%−16.9%
FY226.4%−26.1%−30.9%
FY21−5.4%−43.3%−39.9%
FY20-−13.8%−20.3%
FY19-−39.6%−78.7%
FY18---
Free cash flowOperating cash flow minus capital expenditure
−$300M−$200M−$100M$0$100MFY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$69M
FY24$33.3M
FY23−$145.2M
FY22−$208.4M
FY21−$283M
FY20−$119.2M
FY19−$159.9M
FY18-
Returned to shareholdersDividends paid and shares bought back
$0$5M$10M$15M$20MFY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearBuybacks
FY25$18.3M
FY24$1.8M
FY23$0
FY22$0
FY21$147K
FY20$0
FY19$0
FY18-
Net margin vs the sectorMedian of Financials companies filing with the SEC
  • Clover Health Investments, Corp.
  • Financials median
−100%−75%−50%−25%0%25%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearClover Health Investments, Corp.Financials median
FY25−4.4%12.6%
FY24−3.1%13.7%
FY23−16.9%11.5%
FY22−30.9%12.8%
FY21−39.9%18.9%
FY20−20.3%13.3%
FY19−78.7%14.4%
FY18-17.2%